Health-Robotics has partnered with Arabian Health Care Supply Corporation (AHCSC-OLAYAN), a Medical Device, Pharmaceutical Automation and IV Solution provider within the Gulf Cooperation Council (GCC) countries.
As per the five-year exclusive pact, OLAYAN would automate the preparation of life-critical hazardous and non-hazardous IV Admixtures with Health Robotics' CytoCare and IV Station Robots.
AHCSC-OLAYAN, as part of the partnership agreement, would also take delivery of 32 CytoCare Robots and 175 IV Station Robots between now and December 31, 2013 for deployment in the Kingdom of Saudi Arabia, Kuwait, United Arab Emirates, Bahrain, Qatar, Oman, Yemen, Syria, Lebanon, Iraq, Jordan, and Palestine.
"We are very pleased to have been chosen by Health Robotics as their GCC exclusive partner for these exciting new technologies. We are also proud to have been awarded the official tender process at King Faisal Specialist Hospital and Research Centre for both CytoCare and IV Station Robots, the latter in direct competition with IHS' (
News -
Alert) RIVA Robot”, said Othman Abahussein, General Manager, AHCSC-Olayan, in a statement.
“Not only did Health Robotics amply demonstrated the proof that our customers and pharmacy experts demanded, but it did so during this official procurement process at much lesser expense to our customers than the IHS' RIVA Robot, once all the true costs of deployment were accurately verified by the Hospital's Steering Committee. In addition, having had many years' experience with Pyxis, I can honestly say that IV Station has the real potential to revolutionize Pharmacy Automation for IVs patient doses globally", he added.
CytoCare and IV Station solutions have and will greatly contribute to ease global pharmacies' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to decrease life-threatening medication errors and cross-contamination risks. Plus, to work more efficiently, increase throughput, reduce IV waste, and contain spiraling costs.
"Over the past year Health Robotics has significantly added to its already impressive leadership position in the sector of IV Admixtures Automation. The company has solidified its partnership with B (
News -
Alert)|Braun in some European and Asia-Pacific countries; additionally, very positive dividends are beginning to emerge out of the investments we and our business partners have made with CytoCare in North America, Middle East and Japan; and lastly, the company has received an unprecedented positive response to the announcement of its non-hazardous IV medications solution IV Station”, said Werner Rainer, CEO of Health Robotics.
“We are very pleased to be working with such serious partners as AHCSC-OLAYAN. They join a growing list of prestigious health care providers that have adopted our robotic solutions", he said.
Rainer claimed that in the two years, the company has installed more IV robots than all of its competitors have sold in over ten years of operations.
Moreover the company has also received purchase orders for one thousand more robots than all of the competitors combined.
He also expressed happiness at the progress in the hospitals' reception for CytoCare in new countries such as Germany, Australia, Japan, Taiwan, France, Belgium, Czech Republic, Saudi Arabia, United Arab Emirates, Slovakia, Austria, and the United States.
Health Robotics is a global supplier in the automation of life-critical intra-venous patient-specific medication preparation, compounding, and dispensing, providing health care facilities around the world with robotics and software automation solutions.
Anil Sharma is a contributing editor for TMCnet. To read more of Anil's articles, please visit his columnist page.Edited by
Jessica Kostek
